$Regencell Bioscience(RGC.US) has dropped another -23%, with no new fundamental news. The market pressure still stems more from the shadow of that securities class action lawsuit and the earlier regulatory investigation.
Can you still trust this kind of stock that has zero revenue, propped up by a TCM (Traditional Chinese Medicine) concept to a sky-high market cap, and is now entangled in lawsuits? My view is that the fundamentals column was always empty to begin with. What's been lost is the emotional premium that was hyped up earlier. It's still far from reasonable valuation, and any rebound is only suitable for trading on sentiment, not as a value investment.😵
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
